MELISSA RICHART: Open Payments
NPI 1275924847 · MOORESTOWN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,289 in 60 payments from 15 companies in 2025. Trend: 2023 $807 · 2024 $658 · 2025 $1,289
Food & beverage: $1,094Education: $195
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 25 | $488 |
| Janssen Biotech, Inc. | 2 | $195 |
| GENZYME CORPORATION | 5 | $182 |
| UCB, Inc. | 5 | $87 |
| LEO Pharma Inc. | 5 | $75 |
| Organon LLC | 6 | $68 |
| Amgen Inc. | 3 | $49 |
| Regeneron Healthcare Solutions, Inc. | 2 | $33 |
| Botanix SB Inc | 1 | $18 |
| Incyte Corporation | 1 | $17 |
Products named: SKYRIZI, DUPIXENT, TREMFYA, RINVOQ, Bimzelx, ADBRY, OTEZLA, SOFDRA.
Industry payments across NJ — which companies pay providers there.
